Literature DB >> 17136027

Vascular function in patients with end-stage renal disease and/or coronary artery disease: a cardiac magnetic resonance imaging study.

L U Zimmerli1, P B Mark, T Steedman, J E Foster, G A Berg, H J Dargie, A G Jardine, C Delles, A F Dominiczak.   

Abstract

Decreased arterial compliance in end-stage renal disease (ESRD) is associated with increased cardiovascular risk. Our aim was to examine aortic compliance in patients with ESRD using cardiac magnetic resonance imaging (MRI) and to compare these with patients with advanced atherosclerotic disease who are known to be at high cardiovascular risk. We examined a total of 83 subjects matched for age: 24 had ESRD and were on dialysis therapy for 3+/-6 years, 24 had severe coronary artery disease (CAD), 11 had both ESRD and CAD (4+/-5 years on dialysis therapy), and 24 healthy subjects with no evidence of CAD. Vascular and cardiac function was assessed using cardiac MRI. Aortic compliance was significantly reduced in patients with CAD compared to control subjects (11.3+/-6.3 ml x 10(-3)/mm Hg vs 15.6+/-6.0 ml x 10(-3)/mm Hg, P=0.009). Patients with ESRD also exhibited significantly reduced aortic compliance compared to healthy controls (12.4+/-5.8 ml x 10(-3)/mm Hg vs 15.6+/-6.0 ml 10(-3)/mm Hg, P=0.012), whereas there was no significant difference in aortic compliance between patients with CAD and ESRD. Even in the absence of symptomatic CAD, patients with ESRD have significantly reduced aortic compliance compared to normal subjects. Patients with ESRD have equivalent aortic compliance to patients with advanced CAD. These findings suggest that a significantly reduced aortic compliance is one of many mechanisms promoting premature cardiovascular events in patients with ESRD compared to age-matched controls from the general population.

Entities:  

Mesh:

Year:  2006        PMID: 17136027     DOI: 10.1038/sj.ki.5002024

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  14 in total

1.  Renal function and cardiovascular events: relevance of eGFR and albuminuria in patients with diabetes.

Authors:  C Delles; A G Jardine
Journal:  Diabetologia       Date:  2010-10-13       Impact factor: 10.122

2.  Alterations in vascular function in primary aldosteronism: a cardiovascular magnetic resonance imaging study.

Authors:  P B Mark; S Boyle; L U Zimmerli; E P McQuarrie; C Delles; E M Freel
Journal:  J Hum Hypertens       Date:  2013-07-25       Impact factor: 3.012

Review 3.  Noninvasive imaging for assessment of calcification in chronic kidney disease.

Authors:  Cristina Karohl; Luis D'Marco Gascón; Paolo Raggi
Journal:  Nat Rev Nephrol       Date:  2011-08-23       Impact factor: 28.314

4.  The deleterious effects of arteriovenous fistula-creation on the cardiovascular system: a longitudinal magnetic resonance imaging study.

Authors:  Benjamin K Dundon; Kim Torpey; Adam J Nelson; Dennis Tl Wong; Rae F Duncan; Ian T Meredith; Randall J Faull; Stephen G Worthley; Matthew I Worthley
Journal:  Int J Nephrol Renovasc Dis       Date:  2014-09-16

5.  Cardiovascular magnetic resonance for the detection of descending thoracic aorta calcification in patients with end-stage renal disease.

Authors:  Elbert Edy; Alastair J Rankin; Patrick B Mark; Giles H Roditi; Jennifer S Lees; Pauline Hall Barrientos; Rosemary Woodward; Sokratis Stoumpos; Ioannis Koktzoglou; Robert R Edelman; Aleksandra Radjenovic
Journal:  J Cardiovasc Magn Reson       Date:  2021-06-24       Impact factor: 5.364

6.  Impaired renal function impacts negatively on vascular stiffness in patients with coronary artery disease.

Authors:  Sabrina H Rossi; Emily P McQuarrie; William H Miller; Ruth M Mackenzie; Jane A Dymott; María U Moreno; Chiara Taurino; Ashley M Miller; Ulf Neisius; Geoffrey A Berg; Zivile Valuckiene; Jonathan A Hannay; Anna F Dominiczak; Christian Delles
Journal:  BMC Nephrol       Date:  2013-08-13       Impact factor: 2.388

7.  Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease.

Authors:  Patrick B Mark; Arthur Doyle; Kevin G Blyth; Rajan K Patel; Robin A P Weir; Tracey Steedman; John E Foster; Henry J Dargie; Alan G Jardine
Journal:  J Cardiovasc Magn Reson       Date:  2008-08-18       Impact factor: 5.364

8.  Characterisation of cardiomyopathy by cardiac and aortic magnetic resonance in patients new to hemodialysis.

Authors:  Aghogho Odudu; Mohamed Tarek Eldehni; Gerry P McCann; Mark A Horsfield; Tobias Breidthardt; Christopher W McIntyre
Journal:  Eur Radiol       Date:  2015-12-17       Impact factor: 5.315

9.  The importance of accurate measurement of aortic stiffness in patients with chronic kidney disease and end-stage renal disease.

Authors:  Sherna F Adenwalla; Matthew P M Graham-Brown; Francesca M T Leone; James O Burton; Gerry P McCann
Journal:  Clin Kidney J       Date:  2017-05-10

Review 10.  Nutraceuticals as therapeutic agents for atherosclerosis.

Authors:  Joe W E Moss; Jessica O Williams; Dipak P Ramji
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-02-14       Impact factor: 5.187

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.